JPRN-UMIN000005979招募中未知
Phase II study of weekly Nab-paclitaxel followed by FEC as Neoadjuvant Chemotherapy for Breast Cancer - Phase II study of weekly Nab-paclitaxel followed by FEC as Neoadjuvant Chemotherapy for Breast Cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Allergy of the medication 2) Synchronous or metachronous (within 5 years) double cancers 3) Serious complication 4) Contraindication to the study drugs 5) Peripheral neuropathy 6) Pregnancy, breast feeding or wish of future bearing 7) Patients considered inappropriate by the study investigator
研究者
相似试验
已完成
2 期
A phase 2 study of weekly Nab-Paclitaxel followed by FEC (Fluorouracil, Epirubicin, Cyclophosphamide) as primary therapy for operable breast cancerBreast cancerJPRN-UMIN000007510ahanishi Clinic30
已完成
2 期
Phase II study of weekly nab-paclitaxel in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy.JPRN-UMIN000013390ational Hospital Organization Asahikawa Medical center40
已完成
1 期
Phase I/II study of biweekly nab-paclitaxel in patients with platinum-pretreated non-small cell lung cancer (NJLCG1402)on-small cell lung cancerJPRN-UMIN000014893orth Japan Lung Cancer Study Group (NJLCG)42
招募中
1 期
A phase II study of weekly nab-paclitaxel plus ramucirumab in patients with previously treated advanced gastric cancergastric cancerJPRN-UMIN000031285Department of Gastroenterological, Breast and Endocrine Surgery,Yamaguchi University Graduate School of Medicine46
招募中
2 期
Phese 2 trial of weekly nab-paclitaxel in combination with gemcitabine in patients with metastatic breast cancer who have failed prior chemotherapyMetastatic and Recurrenced Breast CancerJPRN-UMIN000009153Toho University Omori Medical Center20